Modulation of norepinephrine by cannabinoids
Modulation of norepinephrine by cannabinoids
批准号:
9230350
负责人:
ELISABETH J VAN BOCKSTAELE
金额:
$31.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2021-02-28
关键词:
AcuteAdrenergic AgentsAdrenergic ReceptorAffectAgonistAnatomyAnxiety DisordersAreaArousalAttentionBehaviorBrainCNR1 geneCannabinoidsCell surfaceChronic stressCognitiveDSP 4DataDevelopmentElectrophysiology (science)ElementsEmotionalEndocannabinoidsEnvironmentExposure toFire - disastersFundingImmunotoxinsKnockout MiceKnowledgeLesionMeasuresMedialMediatingMental disordersMessenger RNAMetabolismModelingMolecularNatureNeuronsNorepinephrinePathologicPathway interactionsPatternPhysiologyPositioning AttributePrefrontal CortexProsencephalonRattusRecording of previous eventsRegulationResolutionRoleSiteSliceSourceStressSymptomsSynapsesSystemTestingTherapeuticTyrosine 3-Monooxygenaseacute stressanxiety-like behaviorbiological adaptation to stressbrain circuitrycannabinoid receptorendogenous cannabinoid systemflexibilityimprovedindexinginterestlocus ceruleus structuremouse modelneurochemistrynoradrenergicnorepinephrine systemnovelnovel therapeuticspreclinical studypublic health relevancereceptorreceptor expressionresponsesynthetic cannabinoidtransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The noradrenergic system continues to be an important target in the development of new therapies for anxiety disorders because of its critical role in the modulation of emotional state and regulation of arousal and stress responses. Synthetic cannabinoid receptor agonists/antagonists and compounds targeting endocannabinoid synthesis/metabolism in brain have received widespread attention as these approaches may hold some therapeutic potential for psychiatric disorders. Over the prior funding period, we demonstrated that the coeruleo-cortical pathway is an important target of cannabinoid actions. We provided evidence that, under basal conditions, exposure to a synthetic cannabinoid receptor agonist increases anxiety- like behaviors that correlate with increases in multiple indices of brain noradrenergic activity. We also provided the first evidence of alterations in expression levels for several adrenergic receptor subtypes in cortical and limbic
areas following acute and repeated exposure to cannabinoid receptor agonists. Finally, we established that noradrenergic transmission in limbic circuitry is critical for selected cannabinoi-induced behaviors. In the competing renewal application, circuit and cellular level studies are proposed to refine our model of how the noradrenergic system is regulated by the endocannabinoid system under conditions of stress. AIM 1 will define how molecular elements of the endocannabinoid system are positioned to impact the coeruleo-cortical pathway. AIM 2 builds on studies in AIM 1 by investigating the regulation of cortical endocannabinoid levels by noradrenergic circuitry. AIM 3 will determine if deletion of the cannabinoid type 1 receptor alters
molecular and electrophysiological indices of noradrenergic activity. Finally, AIM 4 will identify stress-induced molecular and cellular adaptations in cannabinoid modulation of the coeruleo-cortical pathway. Understanding the nature of state dependent alterations of this integrative system may provide a novel substrate for the treatment of stress-induced anxiety disorders.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Cannabinoid receptor signaling and modulation of monoamines: implications for psychiatric and neurological disorders.
大麻素受体信号传导和单胺调节:对精神和神经系统疾病的影响。
DOI:
10.1016/j.pnpbp.2012.01.002
发表时间:
2012
期刊:
Progress in neuro-psychopharmacology & biological psychiatry
影响因子:
5.6
作者:
[VanBockstaele,ElisabethJ]
通讯作者:
VanBockstaele,ElisabethJ
DOI:
10.1111/ejn.14714
发表时间:
2020-07
期刊:
The European journal of neuroscience
影响因子:
--
作者:
[Ross JA, Van Bockstaele EJ]
通讯作者:
Van Bockstaele EJ
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.
DOI:
10.1517/17460441.2014.966680
发表时间:
2015-01
期刊:
Expert opinion on drug discovery
影响因子:
6.3
作者:
[Wyrofsky R, McGonigle P, Van Bockstaele EJ]
通讯作者:
Van Bockstaele EJ
Noradrenergic depletion causes sex specific alterations in the endocannabinoid system in the Murine prefrontal cortex.
去甲肾上腺素能耗竭会导致小鼠前额皮质内源性大麻素系统发生性别特异性改变。
DOI:
10.1016/j.ynstr.2019.100164
发表时间:
2019
期刊:
Neurobiology of stress
影响因子:
5
作者:
[Urquhart,MA, Ross,JA, Reyes,BAS, Nitikman,M, Thomas,SA, Mackie,K, VanBockstaele,EJ]
通讯作者:
VanBockstaele,EJ
DOI:
10.1002/jnr.22158
发表时间:
2009-12
期刊:
JOURNAL OF NEUROSCIENCE RESEARCH
影响因子:
4.2
作者:
[Reyes, B. A. S., Rosario, J. C., Piana, P. M. T., Van Bockstaele, E. J.]
通讯作者:
Van Bockstaele, E. J.
共 10 条
Modulation of norepinephrine by cannabinoids
-
批准号:7087057
-
项目类别:
-
资助金额:$26.49万
-
财政年份:2005
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Modulation of norepinephrine by cannabinoids
-
批准号:8503933
-
项目类别:
-
资助金额:$34.17万
-
财政年份:2005
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Modulation of norepinephrine by cannabinoids
-
批准号:8670706
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2005
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Modulation of norepinephrine by cannabinoids
-
批准号:8821591
-
项目类别:
-
资助金额:$45.91万
-
财政年份:2005
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Modulation of norepinephrine by cannabinoids
-
批准号:7600515
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2005
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Modulation of norepinephrine by cannabinoids
-
批准号:7854179
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2005
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Modulation of norepinephrine by cannabinoids
-
批准号:9271435
-
项目类别:
-
资助金额:$0.58万
-
财政年份:2005
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Modulation of norepinephrine by cannabinoids
-
批准号:7640056
-
项目类别:
-
资助金额:$0.96万
-
财政年份:2005
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Modulation of norepinephrine by cannabinoids
-
批准号:8739959
-
项目类别:
-
资助金额:$14.16万
-
财政年份:2005
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Modulation of norepinephrine by cannabinoids
-
批准号:7393786
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2005
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Modulation of norepinephrine by cannabinoids
-
批准号:7209766
-
项目类别:
-
资助金额:$33.07万
-
财政年份:2005
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Modulation of norepinephrine by cannabinoids
-
批准号:6959244
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2005
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Very Low Naltrexone Treatment of Opiate Withdrawal
-
批准号:6711691
-
项目类别:
-
资助金额:$15.7万
-
财政年份:2003
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Very Low Naltrexone Treatment of Opiate Withdrawal
-
批准号:6579654
-
项目类别:
-
资助金额:$15.7万
-
财政年份:2003
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Very Low Naltrexone Treatment of Opiate Withdrawal
-
批准号:6866456
-
项目类别:
-
资助金额:$15.7万
-
财政年份:2003
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Opioids, Stress and Noradrenergic Neurons
-
批准号:7084600
-
项目类别:
-
资助金额:$12.44万
-
财政年份:2002
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Opioids, Stress and Noradrenergic Neurons
-
批准号:6917941
-
项目类别:
-
资助金额:$12.43万
-
财政年份:2002
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Opioids, Stress and Noradrenergic Neurons
-
批准号:6646418
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2002
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Opioids, Stress and Noradrenergic Neurons
-
批准号:6779133
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2002
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
Opioids, Stress and Noradrenergic Neurons
-
批准号:6508712
-
项目类别:
-
资助金额:$11.41万
-
财政年份:2002
-
负责人:ELISABETH J VAN BOCKSTAELE
-
依托单位:
海外基金